Status:
RECRUITING
Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
Lead Sponsor:
Antonios Likourezos
Conditions:
Urinary Tract Infections
Eligibility:
FEMALE
14-110 years
Brief Summary
The purpose of this study is to determine if a single dose of amikacin (a type of antibiotic) can be used to effectively treat emergency department patients with uncomplicated cystitis (inflammation o...
Detailed Description
he study is a prospective open-label cohort study that seeks to enroll 75 ED patients diagnosed with uncomplicated cystitis. Enrolled patients will be treated with a single dose of amikacin. The prima...
Eligibility Criteria
Inclusion
- female emergency medicine patients
- ≥14 years of age
- uncomplicated urinary tract infection
- a primary urinary complaint and nitrite-positive urine.
Exclusion
- pregnancy
- abnormal genitourinary tract
- recent urinary tract instrumentation
- immunosuppression
- CrCl \< 25 mL/min
- evidence of pyelonephritis or sepsis
- any antibiotic treatment within 30 days
- not available for phone follow-up in 3, 7, and 30 days
- requires admission to the hospital
- abnormal mental status.
Key Trial Info
Start Date :
September 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05227937
Start Date
September 21 2022
End Date
December 31 2025
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maimonides Medical Center
Brooklyn, New York, United States, 11219